Anís began his career in the biopharma industry, pursuing immunology & fibrosis research at UCB, cancer epigenetics research at Boehringer Ingelheim, and GMP Quality Assurance at Lonza Biologics. He was later a Clarendon Scholar at the University of Oxford, where his PhD explored the immune microenvironment in breast cancer using single-cell genomics. He also holds an MSc in Immunology from the University of Oxford, a BSc in Biochemistry from the University of Manchester, and has co-authored research articles published in high-impact journals including Nature Genetics. At DSV, Anís helps build companies developing curative therapeutics across a range of disease areas.
BioTech, Pharma
Direktes E-Mail-Muster
KI Outreach Agenten Pitch Writer
Erstelle personalisierte Anschreiben basierend auf den genauen Investitionskriterien...